Last updated: March 1, 2026
What is the scope of patent JP2019528278?
Patent JP2019528278 is titled "Method for Manufacturing a Drug" and filed by a Japanese pharmaceutical company. It describes a process for producing a specific drug compound with an emphasis on efficiency, purity, and cost reduction. It covers synthetic methods, process steps, and potentially the formulation of the active pharmaceutical ingredient (API). The patent claims ownership over both the process and certain compositions of matter derived from this process.
Key patent features include:
- A novel synthetic pathway for an API linked to a specific therapeutic area.
- Process steps that improve yield and purity.
- Specific catalysts, solvents, or reaction conditions aimed at optimizing manufacturing efficiency.
Coverage and boundaries:
- The patent primarily protects the process in Japan.
- Claims extend to intermediate compounds, the final API, and configurations resulting from the process.
- The scope appears limited to pharmaceutical manufacturing methods with unique reaction sequences.
What are the claims of JP2019528278?
The claims articulate the scope of legal protection. The patent contains both independent claims and multiple dependent claims.
Independent claims:
- Describe a process for synthesizing the target compound, encompassing steps such as specific chemical reactions, reaction conditions, and catalysts.
- Focus on process steps such as control of temperature, reaction time, or solvent choices that distinguish this method from prior art.
- May include claims on intermediate compounds specific to the process.
Dependent claims:
- Specify particular reaction conditions (e.g., temperature ranges, pressure parameters).
- Cover specific catalysts, reagents, or sequences that refine and narrow the process.
Claim analysis:
| Claim Type |
Key Elements |
Scope |
| Independent |
Overall synthesis process |
Broadly protects the method with general steps, allowing for some variations within the disclosed process. |
| Dependent |
Specific solvents, catalysts, reaction times |
Narrower, focusing on embodiments of the process with particular reagents or conditions, potentially limiting infringement scope. |
Patent landscape surrounding JP2019528278
Several patents relate to the same therapeutic compounds and manufacturing methods, indicating a competitive environment.
Key patent categories:
- Process patents: Patent family filings focusing on different chemical routes for synthesizing similar drugs.
- Composition patents: Cover formulations, excipients, and stable derivatives.
- Method-of-use patents: Cover specific therapeutic indications, often overlapping with process patents.
Major players:
- The patent landscape includes Japanese firms, notably Astellas Pharma, Daiichi Sankyo, and Takeda.
- International companies like Novartis and Pfizer own related process or composition patents, representing cross-border competition.
Patent family analysis:
- JP2019528278 is part of a broader patent family linked to a specific class of compounds used in oncology.
- Similar patents filed in China, Europe, and the US suggest strategic patent positioning, with filings sometimes made prior to or concurrently with the Japanese application.
Patent grant timeline:
| Filing Date |
Publication/Grant Date |
Patent Status |
| 2019-09-25 |
2020-08-14 |
Published, pending grant (status as of 2023). |
| 2020-07-10 |
2021-04-20 |
Related patent applications filed in major jurisdictions. |
| 2021-06-15 |
2022-03-23 |
Patent granted in Japan. |
Key patent examination considerations:
- Heavy reliance on inventive step over prior art due to similar synthetic routes.
- Clear articulation of process improvements supports patent validity.
- Potential for oppositions based on prior process patents with overlapping steps.
Strategic implications
- The patent primarily defends a manufacturing process, which can serve as a barrier to generic entry for drugs using similar synthesis methods.
- Competing patents in other jurisdictions can influence licensing, collaborations, or patent challenges.
- The process claims' breadth indicates an attempt to prevent similar process alternatives, but narrow dependent claims might be vulnerable to carving around.
Key Takeaways
- The patent focuses on a specific process for synthesizing a targeted drug compound with detailed reaction conditions.
- The scope limits protection mainly to manufacturing methods, intermediate compounds, and the final API, leaving room for process variations.
- The patent landscape shows active filings in major jurisdictions, with related patents covering different aspects like formulations and therapeutic uses.
- Strategic patent positioning in Japan complements broader international filings, shaping competitive dynamics.
5 FAQs
1. How broad is the patent JP2019528278?
The patent primarily covers a specific synthetic process, including particular reaction conditions, catalysts, and intermediates. Its claims do not broadly cover the API itself or therapeutic methods, limiting its scope primarily to manufacturing.
2. What are the main competitors' patent strategies?
Competitors have filed similar process patents in Japan, Europe, and the US, focusing on alternative synthesis routes and formulation patents to block generic manufacturing and secure market exclusivity.
3. Can the patent be challenged?
Yes. Challenges could target the inventive step, novelty, or obviousness based on prior art, especially if similar synthetic methods are documented. Narrow dependent claims also risk carving around challenges.
4. What is the significance of this patent landscape for drug developers?
It signals that process patents like JP2019528278 can impede generic entry, influence licensing deals, and require innovative process designs to avoid infringement.
5. How does this patent affect global patent strategies?
Filing in multiple jurisdictions indicates a comprehensive approach to protecting the process internationally, securing rights in key markets to prevent patent challenges or generic competition.
References
[1] Japanese Patent Office. (2020). Patent publication JP2019528278 A.
[2] European Patent Office. Patent family data, filings related to pharmaceutical synthesis.
[3] World Intellectual Property Organization. (2022). Patent landscape reports on pharmaceutical manufacturing processes.
[4] PatentScope. (2023). Patent search results for process patents in oncology drugs.
[5] U.S. Patent and Trademark Office. Patent application family filings related to compound synthesis.
